Carolina Ferreira is Head of Research and Innovation at RDefine and a PhD student in Health Sciences at the Faculty of Medicine of the University of Coimbra, funded by an FCT PhD grant (10.54499/2021.05312.BD). Her doctoral research explores nutraceutical strategies targeting the gut–immune–CNS axis in Multiple Sclerosis. She holds a Master’s degree in Biomedical Research (Neurosciences) and a Bachelor’s degree in Biochemistry from the University of Coimbra. She completed a 4-month research stay at Baylor College of Medicine, Texas, U.S., in the Therapeutic Microbiology Laboratory, where she gained hands-on experience with anaerobic chambers and mini-bioreactor assays to study bacterial fermentation and gut microbiome dynamics. Her work focuses on preclinical models of neurodegenerative diseases, with strong expertise in animal experimentation and molecular biology techniques (PCR, Western Blot, microscopy). She has authored relevant peer-reviewed review articles, two book chapters, delivered several first-author oral communications at national meetings, contributed to laboratory training of students, and is involved in an international patent for an oral bioactive compound formulation (Pill, Patent nº PCT/IB2021/053124, International Publication Number WO 2021/220099 A1). She holds DGAV certification (Functions A+B) for animal experimentation.